S. Angermeier

发表

Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion—A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM.

T. Zander, E. Maiello, R. Hofheinz, 2020 .

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study

T. Seufferlein, R. Muche, E. Gallmeier, 2019, BMC Cancer.

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.

Jakob Nikolas Kather, M. Ebert, R. Hofheinz, 2022, The Lancet. Healthy longevity.

1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO

V. Heinemann, S. Al-Batran, T. Gaiser, 2022, Annals of Oncology.

Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7) with high rate of signet cell component: Final results of the multicenter, randomized phase II/III trial of the German AIO and Italian GOIM.

T. Zander, E. Maiello, R. Hofheinz, 2022, Journal of Clinical Oncology.

T. Seufferlein, R. Muche, E. Gallmeier, 2019, BMC cancer.

Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM

T. Zander, W. Bechstein, E. Maiello, 2023, International journal of cancer.

Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial

T. Zhan, E. Goekkurt, J. Riera-Knorrenschild, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315)

E. Gallmeier, T. Ettrich, L. Fischer von Weikersthal, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study.

T. Zhan, J. Betge, M. Maenz, 2024, Journal of geriatric oncology.